Global Bioreactors and Fermenters Market Report 2023: Distribution by Type of Product, Fabrication Material, Type of Bioprocess, Type of Biologics, and Key Geographical Regions - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Bioreactors and Fermenters Market: Distribution by Type of Product, Fabrication Material, Type of Bioprocess, Type of Biologics, and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035" report has been added to ResearchAndMarkets.com's offering.

This report features an extensive study of the current market landscape and the likely future potential of the global bioreactors and fermenters market, over the next 12 years. It highlights the efforts of various stakeholders engaged in this rapidly emerging segment of the bioprocess equipment industry.

Since their introduction in 1982, biologics have gained popularity owing to their therapeutic efficacy, favorable safety profiles and ability to treat a wide variety of disease indications, which are otherwise hard to treat. In fact, in the past two decades, over 170 biopharmaceuticals have already been granted approval by the FDA and over 7,500 biological interventions are under evaluation in clinical trials.

It is a well-known fact that the commercial and clinical-scale manufacturing of such complex biomolecules require highly specialized bioprocessing equipment to facilitate the maintenance of ideal conditions, such as optimal temperature, pH, dissolved oxygen, fluid delivery, and other critical process parameters that are essential for steady cell growth. Bioreactors are capable of providing such optimal conditions and are critical to the upstream biomanufacturing process.

These systems are designed to increase the concentration of viable cells, thereby enabling the production of large amounts of recombinant proteins, such as vaccines, fusion proteins, antibodies and enzymes.

Growing Demand for Bioreactors and Fermenters

Over the past 25 years, there has been a steady increase in the sales of biologics, growing at a rate of 12-14% annually. In order cater to this growing demand, over 1,500 commercial scale biomanufacturing and contract manufacturing organization (CMO) facilities, equipped with bioreactors and / or fermenters have been established, globally.

Further, during the COVID-19 pandemic, several companies enhanced their vaccine production capabilities (through capacity expansion / technology upgradation), resulting in a surge in the sales of bioreactors.

Moreover, the transition in the industry from high-volume biologics towards innovative specialized biologics, particularly those focused on treating rare conditions, has created a requirement for flexible manufacturing systems.

Consequently, there is an increasing demand for a diverse range of bioreactor systems (in term of design and mechanism of action), which includes disposable (single-use), stirred-tank, mini / micro, air lift, rocker, perfusion, wave bed, bubble column, fixed-bed, fluidized bed, membrane, packed bed, fibrous bed and photobioreactors. All these developments represent an additional avenue for revenue generation in this growing market.

Role of Bioprocess Equipment Manufacturers

The design aspect of both bioreactors and fermenters, operational across different types of bioprocesses (batch, fed batch and continuous), is a complex engineering task, requiring extensive understanding of cell growth, metabolism, genetic manipulation, and product expression.

As a result, industry and non-industry players producing biomolecules / cellular therapies, are relying on original equipment manufacturers (OEMs) that produce different components of bioreactors, and / or engineering, procurement, and construction (EPCs) companies that integrate all the equipment designed by OEM engineers into a complete performing system.

Manufacturers that are able to offer their clients modern equipment and infrastructure upgrades, effective life cycle management for their products, responsive customer service, expert troubleshooting of equipment issues, and annual maintenance contract to ensure efficient functioning of installed bioreactors without disruption, are the preferred partners.

Current Market Landscape of Bioreactors and Fermenters

The global bioreactors and fermenters market landscape features more than 255 companies, which claim to possess the necessary technical expertise for manufacturing high-quality bioreactors and fermenters, in order to serve the biotechnology and biopharmaceutical industry. The market is currently dominated by small companies (1-50 employees), which represent 56% of the total number of players.

Based on the requirement, bioreactors are produced using different fabrication materials, such as stainless steel, glass, and plastic, and are available in varying dimensions and volumes, ranging from micro-mini (less than 1 mL and 1 to 10 mL) to large-scale (more than 10,000 L). It is interesting to highlight that companies manufacturing miniature and small-scale bioreactors represent nearly 30% of the total players in this market.

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. BIOREACTOR AND FERMENTER MANUFACTURERS: MARKET LANDSCAPE

5. COMPANY COMPETITIVENESS ANALYSIS

6. COMPANY PROFILES

6.1. Chapter Overview

6.2. Applikon Biotechnology (acquired by Getinge)

6.2.1. Company Overview

6.2.2. Product Portfolio

6.2.3. Recent Developments and Future Outlook

6.3. Bionet

6.4. Cytiva

6.5. Eppendorf

6.6. Merck

6.7. Ollital Technology

6.8. Parr Instrument Company

6.9. Sartorius

6.10. Shanghai Bailun Biological Technology

6.11. Solaris Biotech (acquired by Donaldson Company)

6.12. Solida Biotech

6.13. Zhengzhou Laboao Instrument Equipment (LABAO)

7. CAPACITY ANALYSIS

8. CASE STUDY: BIOPROCESS CONTROLLERS AND AUTOMATION SYSTEMS

9. MARKET FORECAST

10. EXECUTIVE INSIGHTS

11. CONCLUDING REMARKS

12. APPENDIX 1: TABULATED DATA

13. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information about this report visit https://www.researchandmarkets.com/r/a82ky9

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900